Strobeck Mark 4
4 · ROCKWELL MEDICAL, INC. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Strobeck Mark
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-10-01$3.69/sh−2,163$7,971→ 147,201 total
Footnotes (1)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $3.67 to $3.69. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.